These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 12170187)

  • 1. Reducing renal accumulation of single-chain Fv against melanoma-associated proteoglycan by coadministration of L-lysine.
    Hamilton S; Odili J; Wilson GD; Kupsch JM
    Melanoma Res; 2002 Aug; 12(4):373-9. PubMed ID: 12170187
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficient in vivo targeting of malignant melanoma by single-chain Fv antibody fragments.
    Kang NV; Hamilton S; Sanders R; Wilson GD; Kupsch JM
    Melanoma Res; 1999 Dec; 9(6):545-56. PubMed ID: 10661765
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo targeting of malignant melanoma by 125Iodine- and 99mTechnetium-labeled single-chain Fv fragments against high molecular weight melanoma-associated antigen.
    Kang N; Hamilton S; Odili J; Wilson G; Kupsch J
    Clin Cancer Res; 2000 Dec; 6(12):4921-31. PubMed ID: 11156253
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improved production by domain inversion of single-chain Fv antibody fragment against high molecular weight proteoglycan for the radioimmunotargeting of melanoma.
    Hamilton S; Odili J; Gundogdu O; Wilson GD; Kupsch JM
    Hybrid Hybridomics; 2001; 20(5-6):351-60. PubMed ID: 11839253
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of human anti-high molecular weight-melanoma-associated antigen single-chain Fv fragments isolated from a phage display antibody library.
    Desai SA; Wang X; Noronha EJ; Kageshita T; Ferrone S
    Cancer Res; 1998 Jun; 58(11):2417-25. PubMed ID: 9622083
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The use of a cocktail of single chain Fv antibody fragments to improve the in vitro and in vivo targeting of melanoma.
    Pacifico MD; Pearl RA; Kupsch JM
    J Exp Clin Cancer Res; 2006 Mar; 25(1):45-53. PubMed ID: 16761617
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics and biodistribution of 177Lu-labeled multivalent single-chain Fv construct of the pancarcinoma monoclonal antibody CC49.
    Chauhan SC; Jain M; Moore ED; Wittel UA; Li J; Gwilt PR; Colcher D; Batra SK
    Eur J Nucl Med Mol Imaging; 2005 Mar; 32(3):264-73. PubMed ID: 15791435
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pretargeted radioimmunotherapy with a single-chain antibody/streptavidin construct and radiolabeled DOTA-biotin: strategies for reduction of the renal dose.
    Förster GJ; Santos EB; Smith-Jones PM; Zanzonico P; Larson SM
    J Nucl Med; 2006 Jan; 47(1):140-9. PubMed ID: 16391198
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Generation and selection of monoclonal antibodies, single-chain Fv and antibody fusion phage specific for human melanoma-associated antigens.
    Kupsch JM; Tidman N; Bishop JA; McKay I; Leigh I; Crowe JS
    Melanoma Res; 1995 Dec; 5(6):403-11. PubMed ID: 8589614
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Numerical selection of optimal tumor imaging agents with application to engineered antibodies.
    Williams LE; Wu AM; Yazaki PJ; Liu A; Raubitschek AA; Shively JE; Wong JY
    Cancer Biother Radiopharm; 2001 Feb; 16(1):25-35. PubMed ID: 11279795
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The in vivo characteristics of genetically engineered divalent and tetravalent single-chain antibody constructs.
    Wittel UA; Jain M; Goel A; Chauhan SC; Colcher D; Batra SK
    Nucl Med Biol; 2005 Feb; 32(2):157-64. PubMed ID: 15721761
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rapid imaging of human melanoma xenografts using an scFv fragment of the human monoclonal antibody H11 labelled with 111In.
    Reilly RM; Maiti PK; Kiarash R; Prashar AK; Fast DG; Entwistle J; Dan ; Narang SA; Foote S; Kaplan HA
    Nucl Med Commun; 2001 May; 22(5):587-95. PubMed ID: 11388583
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Penetratin improves tumor retention of single-chain antibodies: a novel step toward optimization of radioimmunotherapy of solid tumors.
    Jain M; Chauhan SC; Singh AP; Venkatraman G; Colcher D; Batra SK
    Cancer Res; 2005 Sep; 65(17):7840-6. PubMed ID: 16140953
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Melanoma-targeting properties of (99m)technetium-labeled cyclic alpha-melanocyte-stimulating hormone peptide analogues.
    Chen J; Cheng Z; Hoffman TJ; Jurisson SS; Quinn TP
    Cancer Res; 2000 Oct; 60(20):5649-58. PubMed ID: 11059756
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improved biodistribution and radioimmunoimaging with poly(ethylene glycol)-DOTA-conjugated anti-CEA diabody.
    Li L; Yazaki PJ; Anderson AL; Crow D; Colcher D; Wu AM; Williams LE; Wong JY; Raubitschek A; Shively JE
    Bioconjug Chem; 2006; 17(1):68-76. PubMed ID: 16417253
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics and biodistribution of engineered single-chain antibody constructs of MAb CC49 in colon carcinoma xenografts.
    Pavlinkova G; Beresford GW; Booth BJ; Batra SK; Colcher D
    J Nucl Med; 1999 Sep; 40(9):1536-46. PubMed ID: 10492377
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiepidermal growth factor variant III scFv fragment: effect of radioiodination method on tumor targeting and normal tissue clearance.
    Shankar S; Vaidyanathan G; Kuan CT; Bigner DD; Zalutsky MR
    Nucl Med Biol; 2006 Jan; 33(1):101-10. PubMed ID: 16459265
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biokinetics of a F(ab')3 iodine-131 labeled antigen binding construct (Mab 35) directed against CEA in patients with colorectal carcinoma.
    Storto G; Buchegger F; Waibel R; Kuenzi G; Offord RE; Schubiger PA; Gillet M; Delaloye AB
    Cancer Biother Radiopharm; 2001 Oct; 16(5):371-9. PubMed ID: 11776754
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumour localization and pharmacokinetics of iodine-125 human monoclonal IgM antibody (COU-1) and its monomeric and half-monomeric fragments analysed in nude mice grafted with human tumour.
    Ditzel H; Rasmussen JW; Erb K; Jensenius JC
    Eur J Nucl Med; 1992; 19(6):409-17. PubMed ID: 1618232
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased affinity leads to improved selective tumor delivery of single-chain Fv antibodies.
    Adams GP; Schier R; Marshall K; Wolf EJ; McCall AM; Marks JD; Weiner LM
    Cancer Res; 1998 Feb; 58(3):485-90. PubMed ID: 9458094
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.